Zantac / Ranitidine (NDMA Cancer) Attorney in Houston, Texas

Zantac Litigation in Houston

Houston-area Zantac claimants benefit from proximity to MD Anderson Cancer Center, one of the premier oncology institutions globally and a resource for obtaining comprehensive cancer documentation critical to litigation. Texas applies Daubert under Tex. R. Evid. 702, presenting the same type of causation expert challenges that resulted in the federal MDL dismissal. Post-MDL improvements to expert methodology and newly published epidemiological studies may overcome these challenges. Houston plaintiffs' counsel may also coordinate filing in Delaware Superior Court. The federal Zantac MDL (No. 2924, S.D. Florida) was largely dismissed in 2022 after Judge Robin Rosenberg excluded plaintiffs' causation experts under Daubert. However, the Delaware Superior Court under Judge Vivian Medinilla continues to actively hear Zantac cases and has allowed causation experts to proceed. Defendants Sanofi, Boehringer Ingelheim, GSK, and Pfizer are all actively litigating in Delaware. For most claimants, filing in Delaware Superior Court through national plaintiffs' counsel is now the primary path forward.

Documentation for Houston Zantac Claimants

Houston-area Zantac claimants should request pharmacy records from HEB pharmacy (Texas-based), CVS, and Walgreens, as well as prescription records from Harris County or surrounding county physicians. Medical records from MD Anderson, Memorial Hermann, or Houston Methodist documenting cancer staging and treatment are valuable. Texas's 2-year SOL means claimants with 2024 or later diagnoses have active filing windows; contact qualified counsel immediately.